CreditReports.dk
HomeScreen companies

VELOXIS PHARMACEUTICALS A/S Financials, key figures and credit report

CVR number: 26527767 Established 2002 Industry: 72 Scientific research and development
Company contact details
Gdanskgade 18, 2150 Nordhavn info@veloxis.com www.veloxis.com
Net sales 16 587.0 kUSD FY 2018 +30.9% vs 2017
EBIT margin 81.1 % FY 2018 +8.4 pp vs 2017
Net debt -1 650.0 kUSD FY 2018 -108.4% vs 2017
Quick ratio 1.7 FY 2018 -1 vs 2017

Company information

Official name
VELOXIS PHARMACEUTICALS A/S
Personnel
1 person
Established
2002
Company form
Limited company
Industry
  • Expand more icon72Scientific research and development

Data sources and methodology

The information about VELOXIS PHARMACEUTICALS A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2018.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About VELOXIS PHARMACEUTICALS A/S

VELOXIS PHARMACEUTICALS A/S (CVR number: 26527767) is a company from KØBENHAVN. The company reported a net sales of 16.6 mUSD in 2018, demonstrating a growth of 30.9 % compared to the previous year. The operating profit percentage was at 81.1 % (EBIT: 13.5 mUSD), while net earnings were 19.5 mUSD. The profitability of the company measured by Return on Assets (ROA) was 17.4 %, which can be considered excellent and Return on Equity (ROE) was 31.1 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 98.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. VELOXIS PHARMACEUTICALS A/S's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.

Financial information

See financials

Net sales (kUSD)

EBIT (kUSD)

Profitability

Solidity

Key figures (kUSD)

See financials
2014
2015
2016
2017
2018
Volume
Net sales123 395.002 103.003 800.0012 670.0016 587.00
Gross profit120 148.00- 147.003 800.0012 670.0016 587.00
EBIT-56 645.00-28 292.00-7 075.009 217.0013 453.00
Net earnings-33 632.00-25 255.0013 046.0011 668.0019 505.00
Shareholders equity total253 138.0014 034.0034 287.0050 618.0074 706.00
Balance sheet total (assets)291 865.0020 489.0049 170.0078 854.0075 801.00
Net debt-13 719.0011 566.0019 744.00-1 650.00
Profitability
EBIT-%-1 345.3 %- 186.2 %72.7 %81.1 %
ROA-11.1 %-16.7 %-14.2 %19.7 %17.4 %
ROE-12.7 %-18.9 %54.0 %27.5 %31.1 %
ROI-13.0 %-18.9 %-15.6 %20.2 %17.8 %
Economic value added (EVA)-67 670.19-40 417.98-5 803.337 999.485 707.45
Solvency
Equity ratio86.7 %68.5 %69.7 %64.2 %98.6 %
Gearing2.8 %10.6 %40.5 %51.1 %
Relative net indebtedness %- 185.7 %- 416.3 %330.2 %174.4 %-3.3 %
Liquidity
Quick ratio7.22.72.62.71.7
Current ratio7.43.02.62.71.7
Cash and cash equivalents267 883.0015 209.002 335.006 139.001 650.00
Capital use efficiency
Trade debtors turnover (days)0.150.9
Net working capital %199.4 %625.1 %42.1 %31.4 %4.5 %

Variable visualization

ROA FY 2018
17.4%
Rating 70/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2018
98.6%
Rating 80/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of VELOXIS PHARMACEUTICALS A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
… / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Companies in the same industry

Page generated